Anivive was awarded the top Companion Animal Start-up for the Innovation Showcase at the Animal Health, Nutrition & Technology Innovation Europe summit held in London in March.
Startup set to launch Valley fever vaccine in 2023
Dylan Balsz, Anivive founder and CEO, and Dr. Dave Bruyette, DVM and chief medical officer, spoke with Veterinary33 about the status of their vaccine development and what else the future holds for...
Tommaso Albonetti, general manager at Edra Publishing U.S., said the awards highlight the strength of the company’s marketing and communications efforts.
The Stephen & Christine Schwarzman Animal Medical Center in New York City was created to care for pets whose owners could not afford treatment and care. The facility is now one of the world’s...
The global market for veterinary medical equipment is forecast to grow by a CAGR of 9.2% across the next 4 years, according to a report by market analysis company, Reportlinker.com. The growth...
The success of bitcoin, which has affected all market players, is raising questions among retail investors about how, why, and how to position themselves in the cryptocurrency. Certainly, the...
During April, which includes National Dog Bite Prevention Week, the American Veterinary Medical Association collaborates with organizations to provide information to avoid dog bites.
A new study by researchers at New York University’s Grossman School of Medicine, part of NYU Langone Health, found that chemicals thought to be toxic were in animals’ stool specimens.
Nonprofits BISSELL Pet Foundation and Petco Love are giving vaccines to pets throughout the month of March. Vaccinations include distemper, parvovirus, and panleukopenia to name a few.
The worldwide market for artificial insemination in the veterinary sector is forecast to attain a value of $7.4 billion by the end of 2030, according to a report by Grand View Research, Inc. The...
Pet wellness company, Petco Health and Wellness Company Inc., has entered into an agreement to buy 50% of a stake in Thrive Pet Healthcare and its veterinary hospitals. Currently, Thrive manages 100...
The design of bacteriophage therapies to treat infections caused by Salmonella and Eschericia coli, both of which are multi-resistant to known antibiotics, is the focus of this One Health work.
